BEN OHLSTEIN LABORATORY

Research Focus

Adult stem cells play a critical role in maintaining and repairing damaged tissues and organs over the course of our life. This is especially true for organs like the skin and the intestines whose cells have high turnover rates and need to link the production of new cells with the loss of old cells to keep tissues healthy and functioning. When these mechanisms become corrupted or break down, there can be serious consequences, including compromised tissue function, overgrowth of cells, and cancer.

Using the Drosophila intestine as a model, our lab is working to better understand the mechanisms that guide normal and abnormal tissue functions, particularly in gastrointestinal organs such as the small and large intestines and stomach. We are employing a combination of genetic, biochemical, and biological approaches to precisely determine how intestinal stem cell division, number, and differentiation occurs throughout the course of normal development. Ultimately, a better understanding of the biology of the Drosophila intestinal stem cells will help with diagnosis, treatment, and cures of various conditions that affect the human gastrointestinal tract.

Stem Cell Niches

Research Projects

Intestinal Stem Cell Proliferation and Tissue Homeostasis

Amitosis

Stem Cell Niches

Intestinal Stem Cell Proliferation and Tissue Homeostasis

Enterocytes secrete various ligands to promote the proliferation of intestinal stem cells (ISCs) in response to injury, ensuring rapid tissue repair. However, ISCs must return to basal self-renewal rates to avoid overgrowth after tissue repair. Currently, the mechanisms that prevent hyperplasia following injury remain largely unknown.

Our published findings indicate that the bone morphogenetic protein (BMP) signaling pathway is activated in response to injury to suppress ISC proliferation. These findings also provide evidence for how co-regulation of antagonistic signals mediates tissue homeostasis and how disconnect between these signals can lead to abnormal tissue homeostasis (Guo et al., J Cell Biol 2013). Indeed, loss-of-function mutations in the BMP receptor type 1A and mothers against decapentaplegic homolog 4 (SMAD4s) have been found in human gastrointestinal polyposis syndromes, underscoring the importance of the effect of BMP-signaling on proliferation. The BMP-signaling pathway functions in the ISCs to antagonize ISC proliferation following injury. However, the transcriptional downstream targets of BMP signaling remain unknown.

We are currently testing phosphatase and tensin homolog (PTEN) and Wnt signaling as candidate downstream targets of BMP signaling, as they have been established as targets of BMP signaling in the mammalian intestine. In parallel we have performed RNA-seq analysis between wild type and BMP mutant intestines to identify novel evolutionarily conserved downstream targets of BMP-signaling and are currently analyzing the results in both fly and mouse tissues. Given the similarities between Drosophila and mammalian intestinal homeostasis, identifying the mechanism by which BMP-signaling regulates ISC proliferation in our model system will presumably have broad clinical implications for the diagnosis and treatment of colon cancer.

Amitosis

Studies of intestinal homeostasis have focused largely on replacement of differentiated cells that are lost due to digestive function and exposure to ingested bacteria and chemical damage. However, mechanisms of ISC replacement have been largely unexplored. To determine if and how Drosophila ISCs are replaced after loss we developed a starvation assay to induce rapid loss of stem cells. Within two days of starvation, severe regional loss of approximately half of the total ISC population in the posterior midgut occurred. Upon re-feeding of starved animals, the ISC number returned to that of controls, demonstrating that mechanisms, currently unknown, are in place toprecisely regulate the ISC number. Studies in other systems have revealed that lost stem cells are replaced bysymmetric divisions of remaining stem cells. However, our analysis demonstrated that generation of new stem cells appeared to proceed through a spindle-independent ploidy reduction of cells in the enterocyte lineage through a process known as amitosis (Lucchetta and Ohlstein, Cell Stem Cell 2017). Amitosis was first recognized as a specialized form of cell division in chicken red bloodcells by Robert Remak in 1841 and has been identified in a vast array of species, from primitive ciliates to mammals, and is implicated in generation of some forms of cancer.

Our work establishes a new paradigm of stem cell replacement involving dedifferentiation of polyploid enterocytes to ISCs and may provide insight into the currently unknown mechanisms of ploidy reduction in tissue homeostasis and cancer. Ploidy reduction has been documented in hepatocytes and ploidy reduction of tumor cells that escape mitotic catastrophe secondary to irradiation has been shown to give rise to a mitotically active population of cells. In addition, we have determined that amitosis initiates in aging animals and upon ISC dysfunction during proliferative demand. As we now have multiple assays that induce ploidy reduction of enterocytes, we can use this model to identify pathways that regulate this enigmatic process and provide mechanistic insight into amitosis and ploidy reduction in other systems.

Stem Cell Niches

Stem cell niches provide microenvironments for stem cell proliferation and maintenance. However, even though the role of niches in the maintenance of tissue homeostasis has been well examined, relatively little is known about their function in establishing stem cell lineages during organogenesis. The cells of the adult Drosophila midgut are generated during larval development from adult midgut progenitors (AMPs). Our lab has identified a novel cell, the peripheral cell (PC), in the Drosophila larval midgut that is generated via Notch signaling by AMPs. The PC signals via BMP and other unidentified pathways to repress AMP differentiation, thereby acting as a niche. We found that this niche provides a holding pen for AMPs to proliferate in an undifferentiated manner during development but then breaks down and losses contact with AMPs during metamorphosis to allow cells of the adult midgut, including ISCs to be established (Mathur et al., Science 2010).

Overall, our work presents a new paradigm where a stem cell can generate its own niche. The ability of a stem cell to generate its own niche lends greater autonomy to stem cells to both regulate their numbers and to vary their locations in a tissue without the constraints of a fixed niche. This ability has important implications in maintaining homeostasis and tissue patterning as well as in cancer biology, where cancerous cells exhibit stem cell-like properties. Using a combination of genetic and cell biological approaches, we are attempting to identify other cellular and molecular mechanisms that explain how PCs regulate stem cell maintenance and enterocyte differentiation.

 

About Dr. Ohlstein

Ben Ohlstein received his bachelor’s degree in liberal arts from the University of Texas at Austin in 1989 and his M.D. and Ph.D. degrees from UT Southwestern Medical Center in 2002. He completed a postdoctoral fellowship at the Carnegie Institution in Baltimore, Maryland, in Allan C. Spradling’s laboratory in 2007. During his time in the Spradling laboratory, he demonstrated that the adult Drosophila midgut, like the adult human intestine, is maintained by multipotent stem cells and that the notch signaling pathway plays a crucial role in how stem cells give rise to enterocytes and enteroendocrine cells.

After his postdoctoral studies, Dr. Ohlstein joined Columbia University Medical Center where he was an associate professor of genetics and development and a member of the Columbia Stem Cell Initiative. He is a Howard Hughes Medical Institute Faculty Scholar. In 2020, Dr. Ohlstein joined the Children’s Medical Center Research Institute at UT Southwestern as an associate professor in pediatrics.

Selected Publications

Wu, S., Yang, Y., Tang, R., Zhang, S., Qin, P., Lin, R., Rafel, N., Lucchetta, E.M., Ohlstein, B., Guo, Z. (2023). Apical-basal polarity precisely determines intestinal stem cell number by regulating Prospero threshold. Cell Rep. 42, 112093. (PubMed)

Abu, F., and Ohlstein, B. (2021). Monitoring Gut Acidification in the Adult Drosophila Intestine. J Vis Exp. doi: 10.3791/63141. (PubMed)

Lucchetta, E.M., and Ohlstein, B. (2017). Amitosis of Polyploid Cells Regenerates Functional Stem Cells in the Drosophila Intestine. ​Cell Stem Cell 20, 609-620. (PubMed)

Guo, Z., and Ohlstein, B. (2015). Bidirectional Notch signaling regulates Drosophila intestinal stem cell multipotency. Science 350, aab0988. (PubMed)

Driver, I., and Ohlstein, B. (2014). Specification of regional intestinal stem cell identity during Drosophila metamorphosis. Development 141, 1848-1856. (PubMed)

Guo, Z., Driver, I., and Ohlstein, B. (2013). Injury-induced BMP signaling negatively regulates Drosophila midgut homeostasis. J Cell Biol. 201, 945-961. (PubMed)

Mathur, D., Bost, A., Driver, I., and Ohlstein, B. (2010). A transient niche regulates the specification of Drosophila intestinal stem cells. Science 327, 210-213. (PubMed)


VIEW ALL

Lab Members

Farhan Abu, Ph.D.

Senior Research Scientist

Eric Shin, B.S.

Research Technician

Grace Ward, B.S.

Research Technician

Xing-Han Zhang, Ph.D.

Research Technician

Alysa Bost, Ph.D.

Postdoctoral Fellow, Cornell University

Graduate Student (2008-2014)

Kate Buzzi, M.D.

Pediatric Gastroenterologist, Cohen Children's Medical Center

Pediatric GI Fellow (2011-2013)

Na Hyun Choi, Ph.D.

Research Scientist, Yonsei University

Postdoctoral Fellow (2008-2011)

Ian Driver, Ph.D.

Head of Bioinformatics at Gordian Biotechnology

Graduate Student (2009-2014)

Zheng Guo, Ph.D.

Professor, Huazhong University of Science and Technology

Postdoctoral Fellow (2011-2017)

Elena Lucchetta, Ph.D.

Associate Research Scientist, Columbia University

Postdoctoral Fellow (2011-2020)

Divya Mathur, Ph.D

Director, Immuno-Oncology, Regeneron Pharmaceuticals

Postdoctoral Fellow (2008-2011)

Neus Rafel, Ph.D.

Medical Writer, Flywheel Partners

Postdoctoral Fellow (2011-2020)